本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Terns Pharmaceuticals, Inc.

2.40
+0.16007.14%
盘后2.450.0450+1.87%16:56 EDT
成交量:89.17万
成交额:211.83万
市值:2.10亿
市盈率:-2.15
高:2.44
开:2.23
低:2.23
收:2.24
数据加载中...
2025/03/20

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/20

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/20

重要事件披露

Form 8-K - Current report
2025/02/24

重要事件披露

Form 8-K - Current report
2025/02/20

重要事件披露

Form 8-K - Current report
2025/02/06

重要事件披露

Form 8-K - Current report
2025/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/03

重要事件披露

Form 8-K - Current report
2024/11/19

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/06

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]